Abstract | BACKGROUND: METHODS: RESULTS: In a cohort of 200 patients, median 24 h urinary excretion of PCS amounted to 457.47 μmol (IQR 252.68 - 697.17). After a median follow-up of 52 months, 25 patients reached the primary endpoint (tertile 1/2/3: 5/6/14 events, log rank P 0.037). Higher urinary excretion of PCS was directly associated with cardiovascular events (univariate hazard ratio per 100 μmol increase: 1.112, P 0.002). In multivariate analysis, urinary excretion of PCS remained a predictor of cardiovascular events, independent of eGFR (hazard ratio 1.120, P 0.002). CONCLUSIONS:
|
Authors | Ruben Poesen, Liesbeth Viaene, Kristin Verbeke, Patrick Augustijns, Bert Bammens, Kathleen Claes, Dirk Kuypers, Pieter Evenepoel, Björn Meijers |
Journal | BMC nephrology
(BMC Nephrol)
Vol. 15
Pg. 87
(Jun 09 2014)
ISSN: 1471-2369 [Electronic] England |
PMID | 24912660
(Publication Type: Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Biomarkers
- Cresols
- 4-cresol
|
Topics |
- Aged
- Aged, 80 and over
- Belgium
(epidemiology)
- Biomarkers
(urine)
- Cardiovascular Diseases
(diagnosis, epidemiology, urine)
- Comorbidity
- Cresols
(pharmacokinetics, urine)
- Female
- Humans
- Incidence
- Intestinal Absorption
- Male
- Middle Aged
- Renal Insufficiency, Chronic
(diagnosis, epidemiology, urine)
- Reproducibility of Results
- Risk Factors
- Sensitivity and Specificity
|